Literature DB >> 6652107

Inhibitory effect of cholesterol on the uptake of liposomes by liver and spleen.

H M Patel, N S Tuzel, B E Ryman.   

Abstract

The effect of cholesterol content of small unilamellar (SUV) and reverse phase (REV) liposomes on blood clearance and tissue distribution has been studied. [14C]Inulin has been used as an aqueous marker of liposomes to represent the uptake of intact liposomes in tissues. The blood clearance of the intravenously-injected SUV and REV liposomes depends on the cholesterol content of liposomes. The cholesterol-free (0 mol%) liposomes are cleared more readily from the circulation than the cholesterol-poor liposomes (20 mol%) and the cholesterol-poor are cleared more rapidly than the cholesterol-rich (46.6 mol%) liposomes. This clearance pattern of liposomes from the circulation is not attributed to the change of size of liposomes due to the increase in cholesterol content of liposomes. However, poor stability of cholesterol-free or cholesterol-poor liposomes in the circulation is partly responsible, but the predominant factor responsible for the observed blood clearance pattern is the inhibitory effect of cholesterol on the uptake of liposomes by reticuloendothelial-rich tissues liver and spleen. Uptake of liposomes by these organs is decreased with increasing cholesterol content of vesicles. It is suggested that to produce liposome preparations with a long circulating half life in vivo it is necessary to inhibit their uptake by liver and spleen.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6652107     DOI: 10.1016/0304-4165(83)90223-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  15 in total

1.  Specific accumulation of cholesterol-rich liposomes in the inflammatory tissue of rats with adjuvant arthritis.

Authors:  W G Love; N Amos; I W Kellaway; B D Williams
Journal:  Ann Rheum Dis       Date:  1990-08       Impact factor: 19.103

2.  Liposomes in chemo- and immunotherapy of cancer.

Authors:  G L Scherphof; T Daemen; H H Spanjer; F H Roerdink
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

3.  Development of systems for targeting the regional lymph nodes for diagnostic imaging: in vivo behaviour of colloidal PEG-coated magnetite nanospheres in the rat following interstitial administration.

Authors:  L Illum; A E Church; M D Butterworth; A Arien; J Whetstone; S S Davis
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

4.  Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus.

Authors:  A I Vitas; R Díaz; C Gamazo
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

5.  Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake.

Authors:  A E Hawley; L Illum; S S Davis
Journal:  Pharm Res       Date:  1997-05       Impact factor: 4.200

6.  Influence of liposome charge and composition on their interaction with human blood serum proteins.

Authors:  T Hernández-Caselles; J Villalaín; J C Gómez-Fernández
Journal:  Mol Cell Biochem       Date:  1993-03-24       Impact factor: 3.396

7.  Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery.

Authors:  Deepa A Rao; M Laird Forrest; Adam W G Alani; Glen S Kwon; Joseph R Robinson
Journal:  J Pharm Sci       Date:  2010-04       Impact factor: 3.534

8.  Phosphatidylserine as a determinant of reticuloendothelial recognition of liposome models of the erythrocyte surface.

Authors:  T M Allen; P Williamson; R A Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

9.  Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers.

Authors:  S Stolnik; S E Dunn; M C Garnett; M C Davies; A G Coombes; D C Taylor; M P Irving; S C Purkiss; T F Tadros; S S Davis
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

10.  Nanoparticle drug loading as a design parameter to improve docetaxel pharmacokinetics and efficacy.

Authors:  Kevin S Chu; Allison N Schorzman; Mathew C Finniss; Charles J Bowerman; Lei Peng; James C Luft; Andrew J Madden; Andrew Z Wang; William C Zamboni; Joseph M DeSimone
Journal:  Biomaterials       Date:  2013-07-27       Impact factor: 12.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.